300318 Stock Overview
Beijing Bohui Innovation Biotechnology Group Co., Ltd. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥5.81 |
52 Week High | CN¥7.17 |
52 Week Low | CN¥3.43 |
Beta | 0.11 |
11 Month Change | 0.87% |
3 Month Change | 8.60% |
1 Year Change | -10.48% |
33 Year Change | -32.44% |
5 Year Change | 50.91% |
Change since IPO | 97.95% |
Recent News & Updates
Shareholder Returns
300318 | CN Medical Equipment | CN Market | |
---|---|---|---|
7D | -8.5% | -5.6% | -6.7% |
1Y | -10.5% | -10.2% | 1.9% |
Return vs Industry: 300318 underperformed the CN Medical Equipment industry which returned -7.8% over the past year.
Return vs Market: 300318 underperformed the CN Market which returned 4% over the past year.
Price Volatility
300318 volatility | |
---|---|
300318 Average Weekly Movement | 8.6% |
Medical Equipment Industry Average Movement | 8.6% |
Market Average Movement | 8.2% |
10% most volatile stocks in CN Market | 12.5% |
10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 300318 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300318's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 1,961 | Zhiwei Shen | www.bohui-tech.com |
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. It offers GenPlex, a microfluidic automated nucleic acid detection system, immunofluorescence detection products, and human trace element detection products; and chemical analysis products, such as atomic fluorescence; mass spectrometry and separation analysis, life sciences related consumables, and ICP spectroscopy.
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Fundamentals Summary
300318 fundamental statistics | |
---|---|
Market cap | CN¥4.75b |
Earnings (TTM) | -CN¥15.35m |
Revenue (TTM) | CN¥885.39m |
5.4x
P/S Ratio-309.2x
P/E RatioIs 300318 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300318 income statement (TTM) | |
---|---|
Revenue | CN¥885.39m |
Cost of Revenue | CN¥450.36m |
Gross Profit | CN¥435.03m |
Other Expenses | CN¥450.38m |
Earnings | -CN¥15.35m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.019 |
Gross Margin | 49.13% |
Net Profit Margin | -1.73% |
Debt/Equity Ratio | 40.4% |
How did 300318 perform over the long term?
See historical performance and comparison